CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
2.100
-0.060 (-2.78%)
At close: Apr 1, 2025, 4:00 PM
2.233
+0.133 (6.33%)
After-hours: Apr 1, 2025, 4:28 PM EDT

CASI Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
28.5433.8843.1130.1715.14
Upgrade
Revenue Growth (YoY)
-15.77%-21.41%42.89%99.25%266.52%
Upgrade
Cost of Revenue
17.3913.8315.8312.569.51
Upgrade
Gross Profit
11.1520.0527.2817.615.63
Upgrade
Selling, General & Admin
41.4441.8437.7838.4127.48
Upgrade
Research & Development
8.929.861614.4211.47
Upgrade
Other Operating Expenses
-0-6.37---
Upgrade
Operating Expenses
50.3645.3353.7752.8338.95
Upgrade
Operating Income
-39.21-25.28-26.49-35.22-33.31
Upgrade
Interest Expense
-0.87----0
Upgrade
Interest & Investment Income
0.540.610.130.320.87
Upgrade
Earnings From Equity Investments
-1.19-0.05-0.85--
Upgrade
Currency Exchange Gain (Loss)
-0.190.23.240.32-1.26
Upgrade
Other Non Operating Income (Expenses)
0.190.760.040.090.08
Upgrade
EBT Excluding Unusual Items
-40.74-23.75-23.93-34.49-33.62
Upgrade
Gain (Loss) on Sale of Investments
1.7-2.59-3.574.84.32
Upgrade
Gain (Loss) on Sale of Assets
0.48--2.06-0.071.15
Upgrade
Asset Writedown
-0.7--8.72--1.54
Upgrade
Other Unusual Items
---0.47-
Upgrade
Pretax Income
-39.26-26.34-38.28-35.84-47.51
Upgrade
Income Tax Expense
--0.081.98--
Upgrade
Earnings From Continuing Operations
-39.26-26.26-40.26-35.84-47.51
Upgrade
Minority Interest in Earnings
--0.68-0.76-0.81-0.78
Upgrade
Net Income
-39.26-26.94-41.01-36.65-48.29
Upgrade
Preferred Dividends & Other Adjustments
-0.02---
Upgrade
Net Income to Common
-39.26-26.96-41.01-36.65-48.29
Upgrade
Shares Outstanding (Basic)
1513141411
Upgrade
Shares Outstanding (Diluted)
1513141411
Upgrade
Shares Change (YoY)
14.82%-2.10%0.27%23.23%15.12%
Upgrade
EPS (Basic)
-2.56-2.02-3.01-2.69-4.37
Upgrade
EPS (Diluted)
-2.56-2.02-3.01-2.69-4.37
Upgrade
Free Cash Flow
-29.45-20.17-26.7-35.79-27.39
Upgrade
Free Cash Flow Per Share
-1.92-1.51-1.96-2.63-2.48
Upgrade
Gross Margin
39.06%59.19%63.28%58.38%37.20%
Upgrade
Operating Margin
-137.41%-74.62%-61.45%-116.74%-220.02%
Upgrade
Profit Margin
-137.57%-79.58%-95.14%-121.50%-318.92%
Upgrade
Free Cash Flow Margin
-103.19%-59.54%-61.94%-118.63%-180.87%
Upgrade
EBITDA
-36.88-21.54-24.07-33.4-31.35
Upgrade
EBITDA Margin
-129.24%-63.58%-55.84%-110.72%-207.08%
Upgrade
D&A For EBITDA
2.333.742.421.821.96
Upgrade
EBIT
-39.21-25.28-26.49-35.22-33.31
Upgrade
EBIT Margin
-137.41%-74.62%-61.45%-116.74%-220.02%
Upgrade
Revenue as Reported
28.5433.8843.1130.1715.14
Upgrade
Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q